10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2022 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 15, 2023) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Revenues | |||
| Premiums | $ 133,229 | 117,373 | 104,109 |
| Product revenue | 14,978 | 12,657 | 10,384 |
| Administrative fees and other revenue | 7,453 | 6,913 | 6,315 |
| Total operating revenue | 155,660 | 136,943 | 120,808 |
| Net investment income | 1,485 | 1,378 | 877 |
| Net (losses) gains on financial instruments | (550) | 318 | 182 |
| Total revenues | 156,595 | 138,639 | 121,867 |
| Expenses | |||
| Benefit expense | 116,487 | 102,645 | 88,045 |
| Cost of products sold | 13,035 | 10,895 | 8,953 |
| Selling, general and administrative expense | 17,686 | 15,914 | 17,450 |
| Interest expense | 851 | 798 | 784 |
| Amortization of other intangible assets | 767 | 441 | 361 |
| Loss on extinguishment of debt | 0 | 21 | 36 |
| Total expenses | 148,826 | 130,714 | 115,629 |
| Income before income tax expense | 7,769 | 7,925 | 6,238 |
| Income tax expense | 1,750 | 1,830 | 1,666 |
| Net income | 6,019 | 6,095 | 4,572 |
| Net loss attributable to noncontrolling interests | 6 | 9 | 0 |
| Shareholders net income | 6,025 | 6,104 | 4,572 |
| Shareholders net income per share | |||
| Basic net income per share | 25.10 | 25.04 | 18.23 |
| Diluted net income per share | 24.81 | 24.73 | 17.98 |
| Dividends per share | 5.12 | 4.52 | 3.80 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |